Travere Therapeutics, Inc. (NASDAQ:TVTX) Given Consensus Recommendation of Moderate Buy by Analysts

Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Rating) have been assigned an average rating of “Moderate Buy” from the thirteen brokerages that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average twelve-month […]

Related Keywords

San Diego ,California ,United States ,Piper Sandler ,Barclays ,Travere Therapeutics Inc ,Cheyne Capital Management United Kingdom ,Sectoral Asset Management Inc ,Armistice Capital ,Alphacentric Advisors ,Garnier Co ,Ensign Peak Advisors Inc ,Nasdaq ,Travere Therapeutics ,Get Rating ,Asset Management ,Capital Management United Kingdom ,Peak Advisors Inc ,Martin Shkreli ,Travere Therapeutics Daily ,Nasdaq Tvtx ,Tvtx ,Medical ,Ratings ,Consensus ,